Zepbound belongs to a class of medications that work with the body's natural hormone signals, and among these, its the first and only medication to activate both the GIP and GLP-1 receptors
In terms of appetite suppression onset, many patients report that tirzepatide produces noticeable effects slightly faster, likely due to its dual GIP/GLP-1 mechanism
Your provider will discuss whether compounded therapy is appropriate for your goals and health profile during your consult
In one double-blind, parallel-group, randomized, placebo-controlled trial, semaglutide was assessed as a weight-loss therapy in children 12-18 years of age with obesity (BMI in the 95 th percentile or higher) or who were overweight (BMI in the 85 th percentile or higher) but who had at least one comorbid condition related to their weight
[DOI] [PubMed] [Google Scholar] 16.Elliott R.M., Morgan L.M., Tredger J.A., Deacon S., Wright J., Marks V
We can actually nudge our natural production of GLP-1, which is the very hormone these medications mimic, through targeted and evidence-based nutritional shifts